✦ LIBER ✦

MP-19.03: Prognosis of primary and non-primary T1G3 bladder cancer: is there any difference?

✍ Scribed by F. Ouaki; O. Celhay; B. Merlet; R. Briffaux; C. Pirès; B. Doré; J. Irani

Book ID: 116948218
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 60 KB
Volume: 70
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2007.06.538

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

756 PROGNOSIS OF PRIMARY AND PROGRESSIVE

756 PROGNOSIS OF PRIMARY AND PROGRESSIVE MUSCLE-INVASIVE UROTHELIAL BLADDER CARCINOMA - IS THERE A DIFFERENCE?

✍ A. Ciudin; A. Molina Cabeza; J. Huguet Pérez; I. Goicoechea Maturana; L. Peri Cu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 175 KB

P026 Prognosis of primary and progressiv

P026 Prognosis of primary and progressive muscle-invasive urothelial bladder carcinoma – Is there a difference?

✍ Ciudin, A.; Diaconu, M.G.; Molina, A.; Huguet, J.; Peri, L.; Ribal, M.J.; Alcara 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

1353 LOCATION OF TUMORS IN EARLY AND LAT

1353 LOCATION OF TUMORS IN EARLY AND LATE RECURRENCES IN PATIENTS WITH T1G3 BLADDER CANCER TREATED WITH OR WITHOUT BCG: IS THERE ANY DIFFERENCE?

✍ Urdaneta, Guillermo; Palou, Juan; Serrano, Miriam; Parada, Rubén; Rodríguez, Osc 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 84 KB

Prognostic significance of non-papillary

Prognostic significance of non-papillary tumor morphology as a predictor of cancer progression and survival in patients with primary T1G3 bladder cancer

✍ Jinsung Park; Cheryn Song; Jun Hyuk Hong; Bong-Hee Park; Yong Mee Cho; Choung-So 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 389 KB

Current opinion on aspirin in primary pr

Current opinion on aspirin in primary prevention of atherosclerotic cardiovascular diseases. Is there any difference between diabetic and non-diabetic patients?

✍ Nussbaumerová, Barbora; Rosolová, Hana 📂 Article 📅 2013 🏛 Czech Society of Cardiology 🌐 English ⚖ 263 KB

1042 LOCATION OF THE TUMOURS IN EARLY AN

1042 LOCATION OF THE TUMOURS IN EARLY AND LATE RECURRENCES IN PATIENTS WITH T1G3 BLADDER TUMOURS TREATED WITH OR WITHOUT BCG: IS THERE ANY DIFFERENCE?

✍ Urdaneta, G.; Palou, J.; Serrano, M.; Parada, R.; Rodríguez, O.; Gausa, L.; Bred 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB